Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Trends in HIV-1 reverse transcriptase resistance-associated mutations and antiretroviral prescription data from 2003-2010.

Antiviral therapy - 1 Jan 2012

Miller Michael D, Haddad Mojgan, Su Cathy, Gibbs Craig, McColl Damian J, Guyer Bill

Abstract excerpt

BACKGROUND: The selection of antiretroviral (ARV) drugs for treatment of HIV-1 infection is based on several factors including potency, toxicity, resistance and ease of administration. Emtricitabine (FTC) or lamivudine (3TC), components of recommended initial ARV regimens, are structurally related and share the same resistance mutation (M184V/I). However they differ with respect to potency and incidence of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenine
Share to Deoxycytidine
Share to Emtricitabine

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Lamivudine

Share to Organophosphonates

Share to Tenofovir

Share to Treatment Failure

Share to Zidovudine

Source

Identifiers

PMID: 22837442
DOI: 10.3851/IMP2266

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Trends in HIV-1 reverse transcriptase resistance-associated mutations and antiretroviral prescription data from 2003-2010.PMID 22837442Read ↗

Changes from 2000 to 2009 in the Prevalence of HIV-1 Containing Drug Resistance-Associated Mutations from Antiretroviral Therapy-Naive, HIV-1-Infected Patients in the United States.Semantic proximity Read ↗

Recent trends and patterns in HIV ‐1 transmitted drug resistance in the United KingdomSemantic proximity Read ↗

HIV type 1 genotypic resistance in a clinical database correlates with antiretroviral utilization.Semantic proximity Read ↗

Evolving patterns of HIV-1 resistance to antiretroviral agents in newly infected individuals.Semantic proximity Read ↗

Changing rates and patterns of drug resistance mutations in antiretroviral-experienced HIV-infected patients.Semantic proximity Read ↗

Temporal Trends in HIV-1 Mutations Used for the Surveillance of Transmitted Drug Resistance.Semantic proximity Read ↗

Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted Human Immunodeficiency Virus Type 1 Drug Resistance in a Large US Clinic Population.Semantic proximity Read ↗

Prevalence of antiretroviral drug resistance and resistance-associated mutations in antiretroviral therapy-naïve HIV-infected individuals from 40 United States cities.Semantic proximity Read ↗

A decade of HIV-1 drug resistance in the United States: trends and characteristics in a large protease/reverse transcriptase and co-receptor tropism database from 2003 to 2012.Semantic proximity Read ↗

National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001-2011.Semantic proximity Read ↗

Prevalence of transmitted drug resistance associated mutations and HIV-1 subtypes in new HIV-1 diagnoses, U.S.-2006.Semantic proximity Read ↗

Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL in 2009: a French nationwide study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.